Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Kukatharmini Tharmaratnam, Emma Hurley, Anthony J. Maxwell, Anthony Howell, Anne Irene Hagen, Marit Muri Holmen, Mary Wilson, Yit Yoong Lim, Dafydd Gareth Evans, Pål Møller, Elaine F. Harkness
Publikováno v:
Hereditary Cancer in Clinical Practice
Evans, D G, Harkness, E F, Howell, A, Wilson, M, Hurley, E, Holmen, M M, Tharmaratnam, K U, Hagen, A I, Lim, Y, Maxwell, A J & Moller, P 2016, ' Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality ', Hereditary cancer in clinical practice, vol. 14, 8 . https://doi.org/10.1186/s13053-016-0048-3, https://doi.org/10.1186/s13053-016-0048-3
Evans, D G, Harkness, E F, Howell, A, Wilson, M, Hurley, E, Holmen, M M, Tharmaratnam, K U, Hagen, A I, Lim, Y, Maxwell, A J & Moller, P 2016, ' Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality ', Hereditary cancer in clinical practice, vol. 14, 8 . https://doi.org/10.1186/s13053-016-0048-3, https://doi.org/10.1186/s13053-016-0048-3
Background The addition of annual MRI screening to mammography has heightened optimism that intensive screening along with improved treatments may substantially improve life expectancy of women at high risk of breast cancer. However, survival data fr